25 XP   0   0   10

Biotest Aktiengesellschaft
Buy, Hold or Sell?

Let's analyse Biotest Aktiengesellschaft together

PenkeI guess you are interested in Biotest Aktiengesellschaft. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biotest Aktiengesellschaft. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Biotest Aktiengesellschaft

I send you an email if I find something interesting about Biotest Aktiengesellschaft.

Quick analysis of Biotest Aktiengesellschaft (30 sec.)










What can you expect buying and holding a share of Biotest Aktiengesellschaft? (30 sec.)

How much money do you get?

How much money do you get?
‚ā¨0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
‚ā¨13.34
Expected worth in 1 year
‚ā¨17.81
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
‚ā¨4.47
Return On Investment
10.9%

For what price can you sell your share?

Current Price per Share
‚ā¨41.00
Expected price per share
‚ā¨40.00 - ‚ā¨41.00
How sure are you?
50%

1. Valuation of Biotest Aktiengesellschaft (5 min.)




Live pricePrice per Share (EOD)

‚ā¨41.00

Intrinsic Value Per Share

‚ā¨-1.00 - ‚ā¨-0.89

Total Value Per Share

‚ā¨12.34 - ‚ā¨12.45

2. Growth of Biotest Aktiengesellschaft (5 min.)




Is Biotest Aktiengesellschaft growing?

Current yearPrevious yearGrowGrow %
How rich?$565.3m$381.4m$116.5m23.4%

How much money is Biotest Aktiengesellschaft making?

Current yearPrevious yearGrowGrow %
Making money$54.8m-$12.6m$67.4m123.1%
Net Profit Margin23.5%-10.0%--

How much money comes from the company's main activities?

3. Financial Health of Biotest Aktiengesellschaft (5 min.)




4. Comparing to competitors in the Other industry (5 min.)




  Industry Rankings (Other)  


Richest
#100 / 394

Most Revenue
#168 / 394

Most Profit
#89 / 394

What can you expect buying and holding a share of Biotest Aktiengesellschaft? (5 min.)

Welcome investor! Biotest Aktiengesellschaft's management wants to use your money to grow the business. In return you get a share of Biotest Aktiengesellschaft.

What can you expect buying and holding a share of Biotest Aktiengesellschaft?

First you should know what it really means to hold a share of Biotest Aktiengesellschaft. And how you can make/lose money.

Speculation

The Price per Share of Biotest Aktiengesellschaft is ‚ā¨41.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biotest Aktiengesellschaft.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biotest Aktiengesellschaft, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ‚ā¨13.34. Based on the TTM, the Book Value Change Per Share is ‚ā¨1.12 per quarter. Based on the YOY, the Book Value Change Per Share is ‚ā¨-0.15 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ‚ā¨0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biotest Aktiengesellschaft.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share
Usd Eps0.801.9%1.383.4%-0.32-0.8%0.080.2%0.070.2%
Usd Book Value Change Per Share0.781.9%1.202.9%-0.16-0.4%0.791.9%0.791.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.781.9%1.202.9%-0.16-0.4%0.791.9%0.791.9%
Usd Price Per Share44.98-45.30-45.38-37.06-36.55-
Price to Earnings Ratio14.08-11.85-22.73-22.95-21.85-
Price-to-Total Gains Ratio57.31-48.56--59.07--91.11--91.11-
Price to Book Ratio3.15-3.66-4.71-3.13-2.98-
Price-to-Total Gains Ratio57.31-48.56--59.07--91.11--91.11-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share43.9069
Number of shares22
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share1.200.79
Usd Total Gains Per Share1.200.79
Gains per Quarter (22 shares)26.3217.46
Gains per Year (22 shares)105.2669.84
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101059507060
202112000140130
303163050210200
404214100279270
505265150349340
606326200419410
707377250489480
808428300559550
909479350629620
100105310400698690

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%5.07.00.041.7%6.012.00.033.3%6.012.00.033.3%6.012.00.033.3%
Book Value Change Per Share4.00.00.0100.0%5.07.00.041.7%6.012.00.033.3%6.012.00.033.3%6.012.00.033.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.018.00.0%0.00.018.00.0%0.00.018.00.0%
Total Gains per Share4.00.00.0100.0%5.07.00.041.7%6.012.00.033.3%6.012.00.033.3%6.012.00.033.3%

Fundamentals of Biotest Aktiengesellschaft

About Biotest Aktiengesellschaft

  • Other
  • 0

There is no Profile data available for BIO.BE.

Fundamental data was last updated by Penke on 2024-06-16 00:01:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Biotest Aktiengesellschaft.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit¬†Biotest Aktiengesellschaft earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare¬†Biotest Aktiengesellschaft to the¬†Other industry mean.
  • A Net Profit Margin of 13.7%¬†means that¬†€0.14 for each €1¬†in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biotest Aktiengesellschaft:

  • The MRQ is 13.7%. The company is making a huge profit. +2
  • The TTM is 23.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ13.7%TTM23.5%-9.8%
TTM23.5%YOY-10.0%+33.5%
TTM23.5%5Y-1.6%+25.0%
5Y-1.6%10Y-1.6%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ13.7%5.6%+8.1%
TTM23.5%5.0%+18.5%
YOY-10.0%6.0%-16.0%
5Y-1.6%6.0%-7.6%
10Y-1.6%6.1%-7.7%
1.1.2. Return on Assets

Shows how efficient Biotest Aktiengesellschaft is using its assets to generate profit.

  • Above 5% is considered healthy¬†but always compare¬†Biotest Aktiengesellschaft to the¬†Other industry mean.
  • 2.0% Return on Assets means that¬†Biotest Aktiengesellschaft generated¬†€0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biotest Aktiengesellschaft:

  • The MRQ is 2.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.0%TTM3.8%-1.7%
TTM3.8%YOY-1.0%+4.8%
TTM3.8%5Y0.1%+3.7%
5Y0.1%10Y0.1%+0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0%1.1%+0.9%
TTM3.8%1.0%+2.8%
YOY-1.0%1.5%-2.5%
5Y0.1%1.1%-1.0%
10Y0.1%1.3%-1.2%
1.1.3. Return on Equity

Shows how efficient Biotest Aktiengesellschaft is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare¬†Biotest Aktiengesellschaft to the¬†Other industry mean.
  • 5.6% Return on Equity means Biotest Aktiengesellschaft generated €0.06¬†for each¬†€1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biotest Aktiengesellschaft:

  • The MRQ is 5.6%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 11.0%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ5.6%TTM11.0%-5.4%
TTM11.0%YOY-3.4%+14.4%
TTM11.0%5Y0.3%+10.7%
5Y0.3%10Y0.3%+0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ5.6%3.4%+2.2%
TTM11.0%3.2%+7.8%
YOY-3.4%4.7%-8.1%
5Y0.3%3.7%-3.4%
10Y0.3%3.7%-3.4%

1.2. Operating Efficiency of Biotest Aktiengesellschaft.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biotest Aktiengesellschaft is operating .

  • Measures how much profit Biotest Aktiengesellschaft makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare¬†Biotest Aktiengesellschaft to the¬†Other industry mean.
  • An Operating Margin of 0.0%¬†means the company generated €0.00 ¬†for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biotest Aktiengesellschaft:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.4%+0.4%
5Y-0.4%10Y-0.2%-0.1%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.6%-9.6%
TTM-9.6%-9.6%
YOY-8.7%-8.7%
5Y-0.4%5.7%-6.1%
10Y-0.2%7.1%-7.3%
1.2.2. Operating Ratio

Measures how efficient Biotest Aktiengesellschaft is keeping operating costs low.

  • Below 1 is considered healthy (always compare to¬†Other industry mean).
  • An Operation Ratio of 1.33 means that the operating costs are €1.33 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 1.334. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.330. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.334TTM1.330+0.004
TTM1.330YOY1.807-0.478
TTM1.3305Y1.703-0.374
5Y1.70310Y1.711-0.008
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3341.227+0.107
TTM1.3301.253+0.077
YOY1.8071.242+0.565
5Y1.7031.258+0.445
10Y1.7111.360+0.351

1.3. Liquidity of Biotest Aktiengesellschaft.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biotest Aktiengesellschaft is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to¬†Other industry mean).
  • A Current Ratio of 2.04¬†means the company has €2.04 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 2.035. The company is able to pay all its short-term debts. +1
  • The TTM is 3.514. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.035TTM3.514-1.478
TTM3.514YOY4.545-1.032
TTM3.5145Y4.366-0.853
5Y4.36610Y4.369-0.002
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0351.411+0.624
TTM3.5141.515+1.999
YOY4.5451.541+3.004
5Y4.3661.538+2.828
10Y4.3691.493+2.876
1.3.2. Quick Ratio

Measures if Biotest Aktiengesellschaft is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but¬†always compare¬†Biotest Aktiengesellschaft to the¬†Other industry mean.
  • A Quick Ratio of 0.55¬†means the company can pay off €0.55 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 0.550. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.948. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.550TTM0.948-0.398
TTM0.948YOY1.049-0.101
TTM0.9485Y1.056-0.108
5Y1.05610Y1.070-0.015
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5500.5500.000
TTM0.9480.570+0.378
YOY1.0490.578+0.471
5Y1.0560.603+0.453
10Y1.0700.603+0.467

1.4. Solvency of Biotest Aktiengesellschaft.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biotest Aktiengesellschaft assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare¬†Biotest Aktiengesellschaft to Other industry mean.
  • A Debt to Asset Ratio of 0.64¬†means that Biotest Aktiengesellschaft assets are¬†financed with 63.5% credit (debt) and the remaining percentage (100% - 63.5%)¬†is financed by its owners/shareholders.¬†

Let's take a look of the Debt to Asset Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 0.635. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.658. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.635TTM0.658-0.023
TTM0.658YOY0.688-0.030
TTM0.6585Y0.632+0.026
5Y0.63210Y0.627+0.005
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6350.531+0.104
TTM0.6580.527+0.131
YOY0.6880.560+0.128
5Y0.6320.562+0.070
10Y0.6270.569+0.058
1.4.2. Debt to Equity Ratio

Measures if Biotest Aktiengesellschaft is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but¬†always compare¬†Biotest Aktiengesellschaft to the¬†Other industry mean.
  • A Debt to Equity ratio of 174.1% means that company has €1.74 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 1.741. The company is just able to pay all its debts with equity.
  • The TTM is 1.938. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.741TTM1.938-0.198
TTM1.938YOY2.211-0.272
TTM1.9385Y1.761+0.178
5Y1.76110Y1.730+0.031
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7411.113+0.628
TTM1.9381.112+0.826
YOY2.2111.272+0.939
5Y1.7611.333+0.428
10Y1.7301.473+0.257

2. Market Valuation of Biotest Aktiengesellschaft

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures¬†how much money you pay¬†for each share for¬†every €1 in earnings Biotest Aktiengesellschaft generates.

  • Above 15 is considered overpriced but¬†always compare¬†Biotest Aktiengesellschaft to the¬†Other industry mean.
  • A PE ratio of 14.08 means the investor is paying €14.08¬†for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biotest Aktiengesellschaft:

  • The EOD is 13.749. Based on the earnings, the company is underpriced. +1
  • The MRQ is 14.085. Based on the earnings, the company is underpriced. +1
  • The TTM is 11.851. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD13.749MRQ14.085-0.335
MRQ14.085TTM11.851+2.234
TTM11.851YOY22.727-10.877
TTM11.8515Y22.946-11.096
5Y22.94610Y21.854+1.093
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD13.74913.582+0.167
MRQ14.08511.135+2.950
TTM11.85110.480+1.371
YOY22.72711.329+11.398
5Y22.94611.709+11.237
10Y21.85412.634+9.220
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biotest Aktiengesellschaft:

  • The EOD is -34.966. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -35.819. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 9.643. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-34.966MRQ-35.819+0.853
MRQ-35.819TTM9.643-45.462
TTM9.643YOY-16.168+25.811
TTM9.6435Y-1.248+10.891
5Y-1.24810Y-1.189-0.059
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD-34.9665.586-40.552
MRQ-35.8195.190-41.009
TTM9.6434.831+4.812
YOY-16.1681.966-18.134
5Y-1.2482.318-3.566
10Y-1.1893.588-4.777
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biotest Aktiengesellschaft is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy¬†(always compare to Other industry mean).
  • A PB ratio of 3.15 means the investor is paying €3.15¬†for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Biotest Aktiengesellschaft:

  • The EOD is 3.073. Based on the equity, the company is fair priced.
  • The MRQ is 3.148. Based on the equity, the company is fair priced.
  • The TTM is 3.661. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.073MRQ3.148-0.075
MRQ3.148TTM3.661-0.512
TTM3.661YOY4.711-1.050
TTM3.6615Y3.132+0.529
5Y3.13210Y2.983+0.149
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD3.0731.648+1.425
MRQ3.1481.273+1.875
TTM3.6611.304+2.357
YOY4.7111.387+3.324
5Y3.1321.516+1.616
10Y2.9831.635+1.348
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Biotest Aktiengesellschaft compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.7331.117-34%-0.152+121%0.741-1%0.741-1%
Book Value Per Share--13.34011.752+14%9.001+48%9.591+39%9.135+46%
Current Ratio--2.0353.514-42%4.545-55%4.366-53%4.369-53%
Debt To Asset Ratio--0.6350.658-4%0.688-8%0.632+1%0.627+1%
Debt To Equity Ratio--1.7411.938-10%2.211-21%1.761-1%1.730+1%
Dividend Per Share----0%-0%-0%-0%
Eps--0.7451.293-42%-0.298+140%0.071+952%0.068+1004%
Free Cash Flow Per Share---0.293-0.066-78%-0.803+174%-0.207-29%-0.207-29%
Free Cash Flow To Equity Per Share---0.293-0.066-78%-0.803+174%-0.207-29%-0.207-29%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.889--------
Intrinsic Value_10Y_min---1.004--------
Intrinsic Value_1Y_max---0.636--------
Intrinsic Value_1Y_min---0.625--------
Intrinsic Value_3Y_max---1.495--------
Intrinsic Value_3Y_min---1.435--------
Intrinsic Value_5Y_max---1.850--------
Intrinsic Value_5Y_min---1.753--------
Market Cap--1662000984.0001673872419.600-1%1676840278.500-1%1280828972.610+30%1219837116.771+36%
Net Profit Margin--0.1370.235-42%-0.100+173%-0.016+111%-0.016+111%
Operating Margin----0%-0%-0.0040%-0.0020%
Operating Ratio--1.3341.330+0%1.807-26%1.703-22%1.711-22%
Pb Ratio3.073-2%3.1483.661-14%4.711-33%3.132+1%2.983+6%
Pe Ratio13.749-2%14.08511.851+19%22.727-38%22.946-39%21.854-36%
Price Per Share41.000-2%42.00042.300-1%42.375-1%34.603+21%34.133+23%
Price To Free Cash Flow Ratio-34.966+2%-35.8199.643-471%-16.168-55%-1.248-97%-1.189-97%
Price To Total Gains Ratio55.946-2%57.31048.560+18%-59.069+203%-91.110+259%-91.110+259%
Quick Ratio--0.5500.948-42%1.049-48%1.056-48%1.070-49%
Return On Assets--0.0200.038-46%-0.010+151%0.001+2332%0.001+2641%
Return On Equity--0.0560.110-49%-0.034+160%0.003+1828%0.003+2013%
Total Gains Per Share--0.7331.117-34%-0.152+121%0.741-1%0.741-1%
Usd Book Value--565328110.000498022045.000+14%381427807.500+48%459351846.000+23%462664496.667+22%
Usd Book Value Change Per Share--0.7851.196-34%-0.162+121%0.794-1%0.794-1%
Usd Book Value Per Share--14.28612.585+14%9.639+48%10.271+39%9.782+46%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.7981.385-42%-0.319+140%0.076+952%0.072+1004%
Usd Free Cash Flow---12422440.000-2784340.000-78%-34027847.500+174%-9166904.000-26%-9133247.143-26%
Usd Free Cash Flow Per Share---0.314-0.070-78%-0.860+174%-0.222-29%-0.222-29%
Usd Free Cash Flow To Equity Per Share---0.314-0.070-78%-0.860+174%-0.222-29%-0.222-29%
Usd Market Cap--1779836853.7661792549974.150-1%1795728254.246-1%1371639746.768+30%1306323568.351+36%
Usd Price Per Share43.907-2%44.97845.299-1%45.379-1%37.056+21%36.553+23%
Usd Profit--31591550.00054803307.500-42%-12636620.000+140%2912848.000+985%2712946.667+1064%
Usd Revenue--230457680.000216937567.500+6%138520915.000+66%149122825.000+55%145973869.048+58%
Usd Total Gains Per Share--0.7851.196-34%-0.162+121%0.794-1%0.794-1%
 EOD+3 -3MRQTTM+10 -22YOY+27 -55Y+18 -1410Y+17 -15

3.2. Fundamental Score

Let's check the fundamental score of Biotest Aktiengesellschaft based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1513.749
Price to Book Ratio (EOD)Between0-13.073
Net Profit Margin (MRQ)Greater than00.137
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.550
Current Ratio (MRQ)Greater than12.035
Debt to Asset Ratio (MRQ)Less than10.635
Debt to Equity Ratio (MRQ)Less than11.741
Return on Equity (MRQ)Greater than0.150.056
Return on Assets (MRQ)Greater than0.050.020
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Biotest Aktiengesellschaft based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.467
Ma 20Greater thanMa 5041.100
Ma 50Greater thanMa 10041.276
Ma 100Greater thanMa 20041.624
OpenGreater thanClose40.000
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets1,446,800
Total Liabilities918,900
Total Stockholder Equity527,900
 As reported
Total Liabilities 918,900
Total Stockholder Equity+ 527,900
Total Assets = 1,446,800

Assets

Total Assets1,446,800
Total Current Assets796,200
Long-term Assets650,600
Total Current Assets
Cash And Cash Equivalents 84,700
Short-term Investments 14,100
Net Receivables 201,000
Inventory 438,700
Other Current Assets 12,200
Total Current Assets  (as reported)796,200
Total Current Assets  (calculated)750,700
+/- 45,500
Long-term Assets
Property Plant Equipment 581,100
Long-term Assets Other 100
Long-term Assets  (as reported)650,600
Long-term Assets  (calculated)581,200
+/- 69,400

Liabilities & Shareholders' Equity

Total Current Liabilities391,200
Long-term Liabilities527,700
Total Stockholder Equity527,900
Total Current Liabilities
Accounts payable 77,200
Other Current Liabilities 16,500
Total Current Liabilities  (as reported)391,200
Total Current Liabilities  (calculated)93,700
+/- 297,500
Long-term Liabilities
Long-term Liabilities  (as reported)527,700
Long-term Liabilities  (calculated)0
+/- 527,700
Total Stockholder Equity
Retained Earnings 268,500
Total Stockholder Equity (as reported)527,900
Total Stockholder Equity (calculated)268,500
+/- 259,400
Other
Capital Stock39,600
Common Stock Shares Outstanding 39,571
Net Invested Capital 527,900
Net Working Capital 405,000
Property Plant and Equipment Gross 581,100



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
1,044,600
1,058,200
1,091,000
1,108,400
1,107,600
1,145,200
1,122,200
1,131,300
1,134,800
1,145,800
1,135,400
1,104,200
1,109,800
1,101,900
1,079,300
1,203,000
1,190,200
1,214,100
1,349,500
1,410,900
1,446,800
1,446,8001,410,9001,349,5001,214,1001,190,2001,203,0001,079,3001,101,9001,109,8001,104,2001,135,4001,145,8001,134,8001,131,3001,122,2001,145,2001,107,6001,108,4001,091,0001,058,2001,044,600
   > Total Current Assets 
476,100
488,600
508,500
522,800
525,600
563,900
542,200
556,300
560,600
570,500
556,600
522,200
523,900
522,000
497,500
619,400
597,400
620,700
736,200
756,500
796,200
796,200756,500736,200620,700597,400619,400497,500522,000523,900522,200556,600570,500560,600556,300542,200563,900525,600522,800508,500488,600476,100
       Cash And Cash Equivalents 
43,400
49,800
65,500
60,800
44,000
63,700
40,200
71,300
55,000
72,000
79,200
104,400
115,300
85,000
53,300
116,600
68,000
58,300
65,400
108,100
84,700
84,700108,10065,40058,30068,000116,60053,30085,000115,300104,40079,20072,00055,00071,30040,20063,70044,00060,80065,50049,80043,400
       Short-term Investments 
52,500
31,900
34,100
24,900
20,600
31,000
32,800
17,900
13,300
13,100
12,100
13,100
14,800
18,100
23,600
20,000
18,900
12,600
13,400
10,400
14,100
14,10010,40013,40012,60018,90020,00023,60018,10014,80013,10012,10013,10013,30017,90032,80031,00020,60024,90034,10031,90052,500
       Net Receivables 
94,200
108,400
104,800
107,700
93,300
112,600
108,900
115,800
122,400
115,100
107,400
107,300
86,200
97,200
93,400
124,500
120,400
149,300
210,300
145,200
201,000
201,000145,200210,300149,300120,400124,50093,40097,20086,200107,300107,400115,100122,400115,800108,900112,60093,300107,700104,800108,40094,200
       Inventory 
236,000
247,000
257,300
280,100
312,400
304,300
306,900
290,100
301,800
303,100
298,100
244,600
255,800
263,200
268,700
293,800
327,600
341,100
373,600
419,100
438,700
438,700419,100373,600341,100327,600293,800268,700263,200255,800244,600298,100303,100301,800290,100306,900304,300312,400280,100257,300247,000236,000
       Other Current Assets 
12,900
10,100
6,900
1,400
9,600
8,400
9,700
1,200
18,700
13,400
12,100
3,100
18,000
15,400
23,600
3,100
20,400
15,300
29,300
2,700
12,200
12,2002,70029,30015,30020,4003,10023,60015,40018,0003,10012,10013,40018,7001,2009,7008,4009,6001,4006,90010,10012,900
   > Long-term Assets 
568,500
569,600
582,500
585,600
582,000
581,300
580,000
575,000
574,200
575,300
578,800
582,000
585,900
579,900
581,800
583,600
592,700
593,400
613,300
654,400
650,600
650,600654,400613,300593,400592,700583,600581,800579,900585,900582,000578,800575,300574,200575,000580,000581,300582,000585,600582,500569,600568,500
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
543,800
547,800
549,600
555,700
573,400
578,400
581,100
581,100578,400573,400555,700549,600547,800543,80000000000000000
       Goodwill 
0
0
0
7,200
0
0
0
7,100
0
0
0
7,100
0
0
0
7,200
0
0
0
6,000
0
06,0000007,2000007,1000007,1000007,200000
       Intangible Assets 
0
0
0
6,600
0
0
0
6,900
0
0
0
4,100
0
0
0
9,200
0
0
0
9,000
0
09,0000009,2000004,1000006,9000006,600000
       Long-term Assets Other 
100
569,600
7,700
100
5,600
3,600
3,700
100
300
100
100
400
500
300
500
100
200
200
200
100
100
1001002002002001005003005004001001003001003,7003,6005,6001007,700569,600100
> Total Liabilities 
550,700
562,000
599,300
631,500
641,400
685,900
678,000
689,700
707,100
723,400
723,200
723,800
734,700
743,200
735,500
831,900
839,100
840,600
889,600
912,000
918,900
918,900912,000889,600840,600839,100831,900735,500743,200734,700723,800723,200723,400707,100689,700678,000685,900641,400631,500599,300562,000550,700
   > Total Current Liabilities 
107,800
415,600
101,100
115,000
123,100
113,800
103,300
105,600
121,100
111,100
103,800
106,400
114,900
122,200
109,600
130,200
129,500
122,800
147,200
385,300
391,200
391,200385,300147,200122,800129,500130,200109,600122,200114,900106,400103,800111,100121,100105,600103,300113,800123,100115,000101,100415,600107,800
       Short-term Debt 
0
0
0
3,300
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000003,300000
       Short Long Term Debt 
0
0
0
3,300
0
0
0
3,500
0
0
0
1,600
0
0
0
4,800
0
0
0
226,800
0
0226,8000004,8000001,6000003,5000003,300000
       Accounts payable 
50,600
63,300
40,100
52,200
54,700
49,000
37,700
42,000
49,300
43,800
31,500
38,800
38,700
42,200
30,200
51,100
44,700
54,500
53,300
78,100
77,200
77,20078,10053,30054,50044,70051,10030,20042,20038,70038,80031,50043,80049,30042,00037,70049,00054,70052,20040,10063,30050,600
       Other Current Liabilities 
25,700
28,900
30,400
7,700
33,100
34,700
33,500
5,900
35,400
39,100
39,500
4,300
14,900
18,900
11,900
4,900
21,100
18,300
20,800
5,800
16,500
16,5005,80020,80018,30021,1004,90011,90018,90014,9004,30039,50039,10035,4005,90033,50034,70033,1007,70030,40028,90025,700
   > Long-term Liabilities 
442,900
146,400
498,200
516,500
518,300
572,100
574,700
584,100
586,000
612,300
619,400
617,400
619,800
621,000
625,900
701,700
709,600
717,800
742,400
526,700
527,700
527,700526,700742,400717,800709,600701,700625,900621,000619,800617,400619,400612,300586,000584,100574,700572,100518,300516,500498,200146,400442,900
       Capital Lease Obligations Min Short Term Debt
0
0
0
23,400
0
0
0
27,400
0
0
0
26,800
0
0
0
29,000
0
0
0
57,800
0
057,80000029,00000026,80000027,40000023,400000
       Long-term Liabilities Other 
100
200
200
300
100
0
0
-600
0
0
0
-1,900
0
0
100
-700
0
0
0
-300
0
0-300000-70010000-1,900000-60000100300200200100
> Total Stockholder Equity
493,900
496,200
491,700
476,900
466,200
459,300
444,200
441,600
427,700
422,400
412,200
380,400
375,100
358,700
343,800
371,100
351,100
373,500
459,900
498,900
527,900
527,900498,900459,900373,500351,100371,100343,800358,700375,100380,400412,200422,400427,700441,600444,200459,300466,200476,900491,700496,200493,900
   Common Stock000000000000000000000
   Retained Earnings 
52,900
234,800
232,300
217,500
206,800
199,900
184,800
182,200
168,300
163,000
152,800
121,000
115,700
99,300
84,400
111,700
91,700
114,100
200,500
239,500
268,500
268,500239,500200,500114,10091,700111,70084,40099,300115,700121,000152,800163,000168,300182,200184,800199,900206,800217,500232,300234,80052,900
   Capital Surplus 000000000000000000000
   Treasury Stock000000000000000000000
   Other Stockholders Equity 000000000000000000000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue684,600
Cost of Revenue-404,300
Gross Profit280,300280,300
 
Operating Income (+$)
Gross Profit280,300
Operating Expense-564,500
Operating Income120,100-284,200
 
Operating Expense (+$)
Research Development66,800
Selling General Administrative81,000
Selling And Marketing Expenses0
Operating Expense564,500147,800
 
Net Interest Income (+$)
Interest Income2,000
Interest Expense-40,000
Other Finance Cost-200
Net Interest Income-38,200
 
Pretax Income (+$)
Operating Income120,100
Net Interest Income-38,200
Other Non-Operating Income Expenses0
Income Before Tax (EBT)106,300120,100
EBIT - interestExpense = -40,000
127,000
167,000
Interest Expense40,000
Earnings Before Interest and Taxes (EBIT)0146,300
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax106,300
Tax Provision--20,700
Net Income From Continuing Ops127,000127,000
Net Income127,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net038,200
 

Technical Analysis of Biotest Aktiengesellschaft
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biotest Aktiengesellschaft. The general trend of Biotest Aktiengesellschaft is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biotest Aktiengesellschaft's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biotest Aktiengesellschaft.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 40.20 < 41.00 < 41.00.

The bearish price targets are: 40.00.

Tweet this
Biotest Aktiengesellschaft Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging¬†trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biotest Aktiengesellschaft. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biotest Aktiengesellschaft Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a¬†lagging momentum¬†indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biotest Aktiengesellschaft. The current macd is -0.14524836.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biotest Aktiengesellschaft price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biotest Aktiengesellschaft. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biotest Aktiengesellschaft price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Biotest Aktiengesellschaft Daily Moving Average Convergence/Divergence (MACD) ChartBiotest Aktiengesellschaft Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biotest Aktiengesellschaft. The current adx is 52.31.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Biotest Aktiengesellschaft shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Biotest Aktiengesellschaft Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows¬†the current trend.
  • Shows¬†potential entry signals.
  • Shows¬†¬†potential exit signals.
  • Can be used to place¬†trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biotest Aktiengesellschaft. The current sar is 41.30.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Biotest Aktiengesellschaft Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum¬†indicator, meaning the signals are instant.
  • Ranges¬†between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biotest Aktiengesellschaft. The current rsi is 47.47. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Biotest Aktiengesellschaft Daily Relative Strength Index (RSI) ChartBiotest Aktiengesellschaft Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading¬†momentum¬†indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges¬†between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biotest Aktiengesellschaft. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biotest Aktiengesellschaft price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Biotest Aktiengesellschaft Daily Stochastic Oscillator ChartBiotest Aktiengesellschaft Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,¬†the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biotest Aktiengesellschaft. The current cci is -139.22764228.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Biotest Aktiengesellschaft Daily Commodity Channel Index (CCI) ChartBiotest Aktiengesellschaft Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biotest Aktiengesellschaft. The current cmo is -1.70171258.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Biotest Aktiengesellschaft Daily Chande Momentum Oscillator (CMO) ChartBiotest Aktiengesellschaft Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and¬†-100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biotest Aktiengesellschaft. The current willr is -37.5.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biotest Aktiengesellschaft is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Biotest Aktiengesellschaft Daily Williams %R ChartBiotest Aktiengesellschaft Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold¬†

Score

Let's take a look at the Bollinger Bands of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biotest Aktiengesellschaft. The current atr is 0.38456499.

Biotest Aktiengesellschaft Daily Average True Range (ATR) ChartBiotest Aktiengesellschaft Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biotest Aktiengesellschaft. The current obv is 233.00.

Biotest Aktiengesellschaft Daily On-Balance Volume (OBV) ChartBiotest Aktiengesellschaft Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biotest Aktiengesellschaft. The current mfi is 24.83.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Biotest Aktiengesellschaft Daily Money Flow Index (MFI) ChartBiotest Aktiengesellschaft Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biotest Aktiengesellschaft.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-27MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-05-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-05-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-31MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-06-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-07BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-06-14STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Biotest Aktiengesellschaft Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biotest Aktiengesellschaft based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.467
Ma 20Greater thanMa 5041.100
Ma 50Greater thanMa 10041.276
Ma 100Greater thanMa 20041.624
OpenGreater thanClose40.000
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Biotest Aktiengesellschaft with someone you think should read this too:
  • Are you bullish or bearish on Biotest Aktiengesellschaft? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biotest Aktiengesellschaft? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biotest Aktiengesellschaft

I send you an email if I find something interesting about Biotest Aktiengesellschaft.


Comments

How you think about this?

Leave a comment

Stay informed about Biotest Aktiengesellschaft.

Receive notifications about Biotest Aktiengesellschaft in your mailbox!